These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 18550747
1. Fourier transform infrared spectroscopy for rapid identification of nonfermenting gram-negative bacteria isolated from sputum samples from cystic fibrosis patients. Bosch A, Miñán A, Vescina C, Degrossi J, Gatti B, Montanaro P, Messina M, Franco M, Vay C, Schmitt J, Naumann D, Yantorno O. J Clin Microbiol; 2008 Aug; 46(8):2535-46. PubMed ID: 18550747 [Abstract] [Full Text] [Related]
2. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. McDowell A, Mahenthiralingam E, Moore JE, Dunbar KE, Webb AK, Dodd ME, Martin SL, Millar BC, Scott CJ, Crowe M, Elborn JS. J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828 [Abstract] [Full Text] [Related]
3. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center. Petrucca A, Cipriani P, Valenti P, Santapaola D, Cimmino C, Scoarughi GL, Santino I, Stefani S, Sessa R, Nicoletti M. Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935 [Abstract] [Full Text] [Related]
4. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center. Manno G, Dalmastri C, Tabacchioni S, Vandamme P, Lorini R, Minicucci L, Romano L, Giannattasio A, Chiarini L, Bevivino A. J Clin Microbiol; 2004 Apr; 42(4):1491-7. PubMed ID: 15070994 [Abstract] [Full Text] [Related]
5. [Use of 16S rRNA gene sequencing for identification of "Pseudomonas-like" isolates from sputum of patients with cystic fibrosis]. Moissenet D, Bingen E, Arlet G, Vu-Thien H. Pathol Biol (Paris); 2005 Apr; 53(8-9):500-2. PubMed ID: 16081224 [Abstract] [Full Text] [Related]
6. Accurate identification of members of the Burkholderia cepacia complex in cystic fibrosis sputum. Martinucci M, Roscetto E, Iula VD, Votsi A, Catania MR, De Gregorio E. Lett Appl Microbiol; 2016 Mar; 62(3):221-9. PubMed ID: 26671758 [Abstract] [Full Text] [Related]
7. [Phenotypic and genotypic characteristics of non fermenting atypical strains recovered from cystic fibrosis patients]. Ferroni A, Sermet-Gaudelus I, Abachin E, Quesnes G, Lenoir G, Berche P, Gaillard JL. Pathol Biol (Paris); 2003 Sep; 51(7):405-11. PubMed ID: 12948761 [Abstract] [Full Text] [Related]
8. Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. van Pelt C, Verduin CM, Goessens WH, Vos MC, Tümmler B, Segonds C, Reubsaet F, Verbrugh H, van Belkum A. J Clin Microbiol; 1999 Jul; 37(7):2158-64. PubMed ID: 10364579 [Abstract] [Full Text] [Related]
9. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum. Kolpen M, Kragh KN, Bjarnsholt T, Line L, Hansen CR, Dalbøge CS, Hansen N, Kühl M, Høiby N, Jensen PØ. Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256 [Abstract] [Full Text] [Related]
10. DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, Vandamme P. J Clin Microbiol; 2000 Sep; 38(9):3165-73. PubMed ID: 10970351 [Abstract] [Full Text] [Related]
11. PCR-based identification and characterization of Burkholderia cepacia complex bacteria from clinical and environmental sources. Seo ST, Tsuchiya K. Lett Appl Microbiol; 2004 Sep; 39(5):413-9. PubMed ID: 15482431 [Abstract] [Full Text] [Related]
12. Use of Fourier transform infrared spectroscopy and chemometrics to discriminate clinical isolates of bacteria of the Burkholderia cepacia complex from different species and ribopatterns. Coutinho CP, Sá-Correia I, Lopes JA. Anal Bioanal Chem; 2009 Aug; 394(8):2161-71. PubMed ID: 19579020 [Abstract] [Full Text] [Related]
13. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients. Degand N, Carbonnelle E, Dauphin B, Beretti JL, Le Bourgeois M, Sermet-Gaudelus I, Segonds C, Berche P, Nassif X, Ferroni A. J Clin Microbiol; 2008 Oct; 46(10):3361-7. PubMed ID: 18685005 [Abstract] [Full Text] [Related]
14. Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation. McDowell A, Mahenthiralingam E, Dunbar KEA, Moore JE, Crowe M, Elborn JS. J Med Microbiol; 2004 Jul; 53(Pt 7):663-668. PubMed ID: 15184539 [Abstract] [Full Text] [Related]
15. Assessment of fluorescent in situ hybridization and PCR-based methods for rapid identification of Burkholderia cepacia complex organisms directly from sputum samples. Brown AR, Govan JR. J Clin Microbiol; 2007 Jun; 45(6):1920-6. PubMed ID: 17460050 [Abstract] [Full Text] [Related]
16. Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients. Liu L, Coenye T, Burns JL, Whitby PW, Stull TL, LiPuma JJ. J Clin Microbiol; 2002 Apr; 40(4):1210-3. PubMed ID: 11923333 [Abstract] [Full Text] [Related]
17. Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update. Devanga Ragupathi NK, Veeraraghavan B. Ann Clin Microbiol Antimicrob; 2019 Feb 04; 18(1):7. PubMed ID: 30717798 [Abstract] [Full Text] [Related]